SCHEMBL8316408

SCHEMBL8316408

CC(C)N1Cc2ccc(F)cc2NS1(=O)=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP8 Q6V1X1 5/20 0.36
DPP9 Q86TI2 5/20 0.36
DPP7 Q9UHL4 5/20 0.36
DPP4 P27487 4/20 0.36
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35
CRY1 Q16526 4/20 0.34
CRY2 Q49AN0 4/20 0.34
PER2 O15055 4/20 0.33
KDM4E B2RXH2 1/20 0.33
RECQL P46063 1/20 0.33
KCNH2 Q12809 1/20 0.33
TMEM97 Q5BJF2 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
GRIA2 P42262 1/20 0.33
PTPN2 P17706 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8318662 0.88 DPP8 (0.36) DPP8DPP9DPP7DPP4CRY1
SCHEMBL2603740 0.80 KDM4E (0.47) KDM4ERECQLKCNH2
SCHEMBL6975709 0.79 PNMT (0.38) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8317304 0.73 DPP7 (0.37) DPP7KCNH2TMEM97SIGMAR1
SCHEMBL8315757 0.72 CA12 (0.36) DPP8DPP9DPP7KDM4ERECQL
SCHEMBL6490844 0.71 KDM4E (0.35) KDM4ERECQL
SCHEMBL8317800 0.71 RYR2 (0.42) KDM4E
SCHEMBL8317166 0.71 KDM4E (0.39) DPP8DPP9DPP7KDM4ERECQL
SCHEMBL6490566 0.70 PNMT (0.38) KDM4ERECQLKCNH2TMEM97SIGMAR1
SCHEMBL6985370 0.70 NAMPT (0.32) KDM4ERECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5929072-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS ELI LILLY AND COMPANY LIMITED (GB) 1999-07-27 US disclosed
EP-0897921-A1 Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands ELI LILLY AND COMPANY LIMITED (GB) 1999-02-24 EP disclosed